A transplantable hepatocarcinoma of guinea pigs has been used as a model for study of immunotherapy of malignant tumors. Cures of established neoplasms have been effected with viable bacillus Calmette-Guerin (BCG); and certain microbial fractions, when presented in association with oil droplets in saline emulsion, have also caused regression of the tumors. P3, a mycobacterial glycolipid (trehalose dimycolate) related to cord factor, although itself inactive, has conferred antitumor properties on several otherwise ineffective materials, including bacterial endotoxins. In the present work, original P3 (isolated from Mycobacterium tuberculosis strain Aoyama B) and several fractions obtained similarly from different sources have been compared for ability to potentiate a particular endotoxin from a O antigen-deficient (Re) mutant of Salmonella typhimurium. All were trehalose mycolates, and all were about equally effective, despite differences in mycolic acid composition. Most significantly, one of the active glycolipids was from the fast-growing nonpathogen, Mycobacterium phlei, and two were monomycolates of trehalose.
Read full abstract